These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25632978)
1. Influence of surface characteristics of modified glass beads as model carriers in dry powder inhalers (DPIs) on the aerosolization performance. Zellnitz S; Schroettner H; Urbanetz NA Drug Dev Ind Pharm; 2015; 41(10):1710-7. PubMed ID: 25632978 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of physically modified glass beads used as model carriers in dry powder inhalers. Zellnitz S; Redlinger-Pohn JD; Kappl M; Schroettner H; Urbanetz NA Int J Pharm; 2013 Apr; 447(1-2):132-8. PubMed ID: 23470233 [TBL] [Abstract][Full Text] [Related]
3. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices. Ooi J; Gill C; Young PM; Traini D Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438 [TBL] [Abstract][Full Text] [Related]
5. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler. de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246 [TBL] [Abstract][Full Text] [Related]
6. Nano- and Microstructured model carrier surfaces to alter dry powder inhaler performance. Renner N; Steckel H; Urbanetz N; Scherließ R Int J Pharm; 2017 Feb; 518(1-2):20-28. PubMed ID: 28025073 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading. Du P; Du J; Smyth HDC J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234 [TBL] [Abstract][Full Text] [Related]
8. Polycaprolactone microspheres as carriers for dry powder inhalers: effect of surface coating on aerosolization of salbutamol sulfate. Tuli RA; Dargaville TR; George GA; Islam N J Pharm Sci; 2012 Feb; 101(2):733-45. PubMed ID: 21956254 [TBL] [Abstract][Full Text] [Related]
9. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers. Young PM; Wood O; Ooi J; Traini D Int J Pharm; 2011 Sep; 416(1):129-35. PubMed ID: 21708238 [TBL] [Abstract][Full Text] [Related]
10. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Zeng XM; MacRitchie HB; Marriott C; Martin GP Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863 [TBL] [Abstract][Full Text] [Related]
11. Chitosan-based binary dry powder inhaler carrier with nanometer roughness for improving in vitro and in vivo aerosolization performance. Huang Y; Huang Z; Zhang X; Zhao Z; Zhang X; Wang K; Ma C; Zhu C; Pan X; Wu C Drug Deliv Transl Res; 2018 Oct; 8(5):1274-1288. PubMed ID: 30112607 [TBL] [Abstract][Full Text] [Related]
12. Effect of Roughness on the Dispersion of Dry Powders for Inhalation: a Dynamic Visualization Perspective. Kou X; Heng PWS; Chan LW; Wereley ST; Carvajal MT AAPS PharmSciTech; 2019 Jul; 20(7):271. PubMed ID: 31363868 [TBL] [Abstract][Full Text] [Related]
13. Dry Powder Inhalers Based on Chitosan-Mannitol Binary Carriers: Effect of the Powder Properties on the Aerosolization Performance. Zhao Z; Wang G; Huang Z; Huang Y; Chen H; Pan X; Zhang X AAPS PharmSciTech; 2022 Jun; 23(5):164. PubMed ID: 35697949 [TBL] [Abstract][Full Text] [Related]
14. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance. Faulhammer E; Wahl V; Zellnitz S; Khinast JG; Paudel A Int J Pharm; 2015 Aug; 491(1-2):231-42. PubMed ID: 26136200 [TBL] [Abstract][Full Text] [Related]
15. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler. Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187 [TBL] [Abstract][Full Text] [Related]
16. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers. Gong QQ; Tay JYS; Veronica N; Xu J; Heng PWS; Zhang YP; Liew CV Pharm Dev Technol; 2023 Feb; 28(2):164-175. PubMed ID: 36683577 [TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol. Kaialy W; Nokhodchi A Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318 [TBL] [Abstract][Full Text] [Related]
18. The clinical relevance of dry powder inhaler performance for drug delivery. Demoly P; Hagedoorn P; de Boer AH; Frijlink HW Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253 [TBL] [Abstract][Full Text] [Related]
20. Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: surface smoothing effects. El-Sabawi D; Edge S; Price R; Young PM Drug Dev Ind Pharm; 2006; 32(10):1135-8. PubMed ID: 17090435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]